Stanford Peng
2018
In 2018, Stanford Peng earned a total compensation of $2M as President and Head of Research and Development at Nivalis Therapeutics, a 273% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $103,300 |
|---|---|
| Option Awards | $1,532,873 |
| Salary | $400,000 |
| Total | $2,036,173 |
Peng received $1.5M in option awards, accounting for 75% of the total pay in 2018.
Peng also received $103.3K in non-equity incentive plan and $400K in salary.
Rankings
In 2018, Stanford Peng's compensation ranked 5,646th out of 14,244 executives tracked by ExecPay. In other words, Peng earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,646 out of 14,244 | 60th |
Division Manufacturing | 2,134 out of 5,765 | 63rd |
Major group Chemicals And Allied Products | 788 out of 2,128 | 63rd |
Industry group Drugs | 658 out of 1,817 | 64th |
Industry Pharmaceutical Preparations | 508 out of 1,391 | 64th |
Source: SEC filing on April 24, 2019.
Peng's colleagues
We found three more compensation records of executives who worked with Stanford Peng at Nivalis Therapeutics in 2018.